Literature DB >> 29422646

Alzheimer disease: APOE ε4 affects cognitive decline but does not block benefits of healthy lifestyle.

Ian Fyfe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29422646     DOI： 10.1038/nrneurol.2018.16

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  2 in total

1.  Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.

Authors:  Yen Ying Lim; Pawel Kalinowski; Robert H Pietrzak; Simon M Laws; Samantha C Burnham; David Ames; Victor L Villemagne; Christopher J Fowler; Stephanie R Rainey-Smith; Ralph N Martins; Christopher C Rowe; Colin L Masters; Paul T Maruff
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

2.  Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial.

Authors:  Alina Solomon; Heidi Turunen; Tiia Ngandu; Markku Peltonen; Esko Levälahti; Seppo Helisalmi; Riitta Antikainen; Lars Bäckman; Tuomo Hänninen; Antti Jula; Tiina Laatikainen; Jenni Lehtisalo; Jaana Lindström; Teemu Paajanen; Satu Pajala; Anna Stigsdotter-Neely; Timo Strandberg; Jaakko Tuomilehto; Hilkka Soininen; Miia Kivipelto
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302
  2 in total
  2 in total

Review 1.  Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease.

Authors:  D Allan Butterfield; Barry Halliwell
Journal:  Nat Rev Neurosci       Date:  2019-03       Impact factor: 38.755

2.  Associations between race, APOE genotype, cognition, and mortality among urban middle-aged white and African American adults.

Authors:  Jordan Weiss; Sharmin Hossain; Ana I Maldonado; Botong Shen; Hind A Beydoun; Mika Kivimaki; Michele K Evans; Alan B Zonderman; May A Beydoun
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.996
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.